The Annals of Internal Medicine heralds a historic moment in the emerging era of open science as it features 2 systematic reviews on rhBMP-2 that are based on patient-level data from all clinical trials conducted by Medtronic, which were shared through the Yale University Open Data Access (YODA) Project.